Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verastem Inc
(NQ:
VSTM
)
3.910
-0.090 (-2.25%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Verastem Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Verastem Oncology Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
November 04, 2021
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Appoints Michelle Robertson to Board of Directors
October 26, 2021
From
Verastem Oncology
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 20, 2021
Gainers Tenet Healthcare (NYSE:THC) stock r...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 27, 2021
Gainers Paratek Pharmaceuticals (NASDAQ:PRTK...
Via
Benzinga
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 24, 2021
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer
September 22, 2021
From
Verastem Oncology
Via
Business Wire
Why Verastem Stock Spiked Today
September 20, 2021
A clinical collaboration with biotech titan Amgen briefly lit a fire underneath Verastem's shares today.
Via
The Motley Fool
Why Verastem Shares Are Trading Higher Today
September 20, 2021
Verastem Inc (NASDAQ: VSTM) is trading higher Monday after the company announced updated investigator-sponsored Phase 1/2 FRAME study data of VS-6766 with defactinib in low-...
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
September 20, 2021
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company...
Via
Benzinga
Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher
September 20, 2021
Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN).
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 20, 2021
Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million....
Via
Benzinga
24 Stocks Moving in Monday's Pre-Market Session
September 20, 2021
Gainers Verastem, Inc. (NASDAQ: VSTM) rose 30.8% to $3.61 in pre-market trading after the company announced a mini oral presentation highlighting updated data from the ongoing...
Via
Benzinga
Verastem Oncology and Amgen Partner to Evaluate VS-6766 in Combination with LUMAKRASTM (Sotorasib) in Patients with KRAS G12C-Mutant Non-Small Cell Lung Cancer
September 20, 2021
From
Verastem Oncology
Via
Business Wire
Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation
September 20, 2021
Verastem Oncology Inc (NASDAQ: VSTM) stock is trading higher after updated data from the ongoing Phase 1/2 FRAME study. The investigator-sponsored study is...
Via
Benzinga
Verastem Oncology Announces Updated Investigator-Sponsored Phase 1/2 FRAME Study Data of VS-6766 with Defactinib in Low-Grade Serous Ovarian Cancer Showing Encouraging Response Rates and Progression-Free Survival Presented at ESMO 2021
September 19, 2021
From
Verastem Oncology
Via
Business Wire
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical...
Via
Benzinga
Exposures
Product Safety
Verastem Oncology to Present at Upcoming Investor Conferences
September 07, 2021
From
Verastem Oncology
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 03, 2021
Gainers Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3...
Via
Benzinga
Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
August 02, 2021
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Announces Updated Phase 1/2 FRAME Study Data in Low Grade Serous Ovarian Cancer Selected for a Mini Oral Presentation at the European Society of Medical Oncology Congress 2021
July 27, 2021
From
Verastem Oncology
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 26, 2021
Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million....
Via
Benzinga
Verastem Oncology Announces Conversion of Senior Notes Eliminating Substantially All Outstanding Debt
July 19, 2021
From
Verastem Oncology
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 12, 2021
Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life...
Via
Benzinga
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 06, 2021
From
Verastem Oncology
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021
July 01, 2021
Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE:
Via
Benzinga
Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors
June 24, 2021
From
Verastem Oncology
Via
Business Wire
44 Biggest Movers From Yesterday
June 23, 2021
Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its...
Via
Benzinga
2 Biotech Penny Stocks That Are Vastly Superior Investments to Dogecoin
June 21, 2021
These unloved cancer stocks should dramatically outperform Dogecoin over the long haul.
Via
The Motley Fool
Stocks That Hit 52-Week Highs On Wednesday
June 16, 2021
Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs. Interesting Facts: Toyota Motor (NYSE:TM) was the largest firm by market cap to set a new 52-...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 15, 2021
Gainers NeuroMetrix (NASDAQ:NURO) stock r...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.